Regional News

EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide

PROVIDENCE, R.I., Dec. 9, 2025 /PRNewswire/ -- EpiVax, Inc. , with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators, announces the publ...

2025-12-09 03:11 1196

Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

* In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as well as in both metastatic and early stage breast cancer. FLORENCE, Italy and NEW YORK, Dec. 8, 2025 /PRNewswire/ -- The Menarini Gro...

2025-12-09 03:05 1505

Abracon Strengthens Global Supply Chain and Quick-Turn Capabilities to Support Growing MEMS Oscillator Demand

AUSTIN, Texas, Dec. 9, 2025 /PRNewswire/ -- Abracon, a leading provider of timing, frequency control, power, magnetics, RF, and antenna solutions, has announced significant enhancements to its global operations to meet the rising demand for its MEMS (Micro-Electro-Mechanical Systems) oscillator p...

2025-12-09 03:00 1009

GameChange BOS Surpasses Orders for 190 Transformers as New Manufacturing Facility Ramps Up

NORWALK, Conn., Dec. 9, 2025 /PRNewswire/ -- GameChange BOS, a division of GameChange Energy, announced that it has surpassed orders for190 medium-voltage transformers, marking a major milestone for the company's expanding product line. The achievement follows the August 2025 opening of GameChan...

2025-12-09 02:04 942

Employers Across APME Signal Intentional Growth as Hiring Outlook Improves to +31% for Q1 2026: Latest ManpowerGroup Employment Outlook Survey

* The Net Employment Outlook (NEO) for Q1 2026 in Asia Pacific and the Middle East (APME) stands at +31%. * With an NEO of +38%, the Information sector and Finance & Insurance sector leads hiring intentions, followed by Tech & IT Services (+37%), and Professional, Scientific & Technical Servi...

2025-12-09 02:00 2991

COSRX Joins the Inaugural Korean American Leaders in Hollywood (KALH) Honors to Celebrate Global Creativity and Representation

LOS ANGELES, Dec. 8, 2025 /PRNewswire/ -- COSRX, the award-winning K-beauty brand trusted worldwide for its science-backed and skin-friendly formulations, proudly served as the official skincare partner of the inaugural Korean American Leaders inHollywood (KALH) Honors, a landmark event recognizi...

2025-12-09 02:00 2069

Imec mitigates thermal bottleneck in 3D HBM-on-GPU architectures using a system-technology co-optimization approach

Holistic system-technology co-optimization (STCO) approach key in reducing peak GPU and HBM temperatures under AI workloads while enhancing performance density of future GPU-based architectures LEUVEN, Belgium, Dec. 9, 2025 /PRNewswire/ -- * Imec presents the first comprehensive thermal study ...

2025-12-09 01:01 1446

Teaching is Not a One-Person Job

Headteacher Joselyn works tirelessly to empower teachers and learners in Uganda's refugee response through an Education Cannot Wait-funded program with support from Save the Children, UNHCR and partners BWEYALE, Uganda, Dec. 9, 2025 /PRNewswire/ -- Joselyn Atyang

2025-12-09 00:56 1006

Moutai Cultural Exhibition Ignites U.S. Audience with Immersive Journey Through a Century of Cultural Heritage

SAN FRANCISCO, Dec. 8, 2025 /PRNewswire/ -- From December 7 to 8, Kweichow Moutai celebrated a dual milestone - the 110th anniversary of its award-winning debut at the 1915 Panama-Pacific International Exposition and the 10th anniversary of San Francisco Moutai Day - through a dynamic series of e...

2025-12-09 00:13 1297

STRADVISION Announces Next Phase of Cloud-Driven Innovation in Collaboration with AWS

-      Head of Data Innovation Center presents STRADVISION's next roadmap at AWS re:Invent SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- STRADVISION , a global leader in AI-based vision perception technology for vehicles, today announced its forward-looking ...

2025-12-09 00:00 1176

2025 Global MOOC and Online Education Conference Held in Mexico

BEIJING, Dec. 8, 2025 /PRNewswire/ -- The 2025 Global MOOC and Online Education Conference, themed "Breaking Boundaries and Reshaping Futures: Open and Intelligent Global Education," was held at theNational Autonomous University of Mexico (UNAM) from Dec 2–4. The opening ceremony featured remarks...

2025-12-08 23:56 612

Convergen Secures $10 Million Seed Funding to Advance TrimTAC Platform for Neurodegeneration & beyond

SUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- Convergen, a biotech company pioneering targeted protein degradation (TPD) therapies for diseases driven by pathological protein aggregates, today announced the closing of a$10 million Seed financing round. The round was invested by Qiming Venture Partn...

2025-12-08 23:00 1422

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement – – Strong activity observed across ESA-refractory and ESA-intolerant patients, and across mutation and morphology subtypes – – Favorable safety profile with no treatment-related serious adverse e...

2025-12-08 22:22 1152

AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C Reports Unaudited Financial Results for the Six Months Ended June 30, 2025

DUBAI, UAE, Dec. 8, 2025 /PRNewswire/ -- AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C, (the "Company") (Nasdaq: AHMA), a United Arabic Emirates-based MICE (meetings, incentives, conferences, and exhibitions) and tourism services provider, today announced its unaudited financial results for the six m...

2025-12-08 22:15 3222

ALR TECHNOLOGIES TO RELAUNCH THE GLUCURVE PET CGM IN JANUARY 2026

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- ALR Technologies SG Ltd ("ALRT" or the " Company") (OTC: ALRTF), the diabetes management company, announces the successful completion of internal manufacturing testing on the GluCurve Pet CGM ("GluCurve") showing accuracy results comparative to the leading v...

2025-12-08 22:14 2837

DXC Appoints Russell Jukes as Chief Digital Information Officer to Strengthen Unified Digital Strategy

ASHBURN, Va., Dec. 8, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading enterprise technology and innovation partner, today announced the appointment ofRussell Jukes as Chief Digital Information Officer (CDIO). In this expanded role, Russell becomes the first to lead DXC's end-to-end dig...

2025-12-08 22:00 1345

PCBAIR Unveils 8-Layer Glass Core PCB Manufacturing for Next-Gen AI & HPC

SHENZHEN, China, Dec. 8, 2025 /PRNewswire/ -- PCBAIR announced the launch of its advanced 8-layer Glass Core PCB manufacturing capabilities, combining proprietary Through Glass Via (TGV) technology with multi-layer redistribution layers (RDL). The new glass substrates achieve superior signal inte...

2025-12-08 22:00 992

Navitas, Cyient Semiconductors enter into a strategic partnership to accelerate GaN adoption in India's AI, Mobility, Industrial, and Energy Markets

TORRANCE, Calif. and HYDERABAD, India, Dec. 8, 2025 /PRNewswire/ -- Navitas Semiconductor Corporation (Nasdaq: NVTS), the industry leader in next-generation GaNFa...

2025-12-08 22:00 1259

Lunit Submits 510(k) Application for Image-Based Breast Cancer Risk Prediction Model

Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk assessment to U.S. screening programs SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that ...

2025-12-08 22:00 1080

Zymedi Announces "rapaprutug" as the International Nonproprietary Name (INN) for ZMA001

INCHEON, South Korea, Dec. 8, 2025 /PRNewswire/ -- Zymedi (CEO Sunghoon Kim) announced that the World Health Organization (WHO) has assignedrapaprutug as the International Nonproprietary Name (INN) for the company's first-in-class antibody therapy ZMA001, being developed as a treatment for pulmon...

2025-12-08 22:00 905